Fortress Biotech
FBIO
$1.75
Share price
-2.78%
Change (1 day)
130.26%
Change (1 year)
Categories
Fortress Biotech (FBIO) - P/B ratio
P/B ratio as of May 2024 : 21.8
According to Fortress Biotech
's latest financial reports the company has a price-to-book ratio of 21.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Fortress Biotech - P/B ratio (from 2011 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 28.1 | 1877.53% |
| 2022-12-31 | 1.42 | 28.97% |
| 2021-12-31 | 1.10 | -27.72% |
| 2020-12-31 | 1.53 | -41.84% |
| 2019-12-31 | 2.62 | 4.1% |
| 2018-12-31 | 2.52 | 50.22% |
| 2017-12-31 | 1.68 | 5.46% |
| 2016-12-31 | 1.59 | 1.9% |
| 2015-12-31 | 1.56 | -2.97% |
| 2014-12-31 | 1.61 | 25.37% |
| 2013-12-31 | 1.28 | -74.31% |
| 2012-12-31 | 4.99 | -20.64% |
| 2011-12-31 | 6.29 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | 1.48 | -93.22% | 🇺🇸 USA |
 Advaxis ADXS | -0.9254 | -104.24% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | 2.47 | -88.70% | 🇺🇸 USA |